Lemaitre Vascular (LMAT) Cash & Current Investments (2016 - 2025)
Lemaitre Vascular (LMAT) has disclosed Cash & Current Investments for 16 consecutive years, with $359.1 million as the latest value for Q4 2025.
- On a quarterly basis, Cash & Current Investments rose 19.82% to $359.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $359.1 million, a 19.82% increase, with the full-year FY2025 number at $359.1 million, up 19.82% from a year prior.
- Cash & Current Investments was $359.1 million for Q4 2025 at Lemaitre Vascular, up from $343.1 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $359.1 million in Q4 2025 to a low of $21.8 million in Q2 2021.
- A 5-year average of $141.7 million and a median of $93.6 million in 2023 define the central range for Cash & Current Investments.
- Peak YoY movement for Cash & Current Investments: dropped 22.5% in 2021, then soared 247.87% in 2022.
- Lemaitre Vascular's Cash & Current Investments stood at $70.0 million in 2021, then increased by 18.2% to $82.7 million in 2022, then grew by 27.07% to $105.1 million in 2023, then skyrocketed by 185.25% to $299.7 million in 2024, then increased by 19.82% to $359.1 million in 2025.
- Per Business Quant, the three most recent readings for LMAT's Cash & Current Investments are $359.1 million (Q4 2025), $343.1 million (Q3 2025), and $319.5 million (Q2 2025).